Skip to main content
Top
Published in: International Journal of Hematology 5/2008

01-12-2008 | Original Article

Dynamics of human erythroblast enucleation

Authors: Miwa Hebiguchi, Makoto Hirokawa, Yong-Mei Guo, Kunie Saito, Hideki Wakui, Atsushi Komatsuda, Naohito Fujishima, Naoto Takahashi, Tsutomu Takahashi, Takehiko Sasaki, Wataru Nunomura, Yuichi Takakuwa, Kenichi Sawada

Published in: International Journal of Hematology | Issue 5/2008

Login to get access

Abstract

How human erythroblasts enucleate remains obscure, and some investigators suspect the effect of mechanical forces on enucleation in vitro. We determined the dynamics of the enucleation process of highly purified human erythroblasts and whether enucleation can occur without external mechanical forces. Highly purified human CD34+ cells were cultured in liquid phase with interleukin-3, stem cell factor and erythropoietin (EPO) for 7 days and the generated erythroblasts were replaced in the same medium with EPO alone. In some experiments, the enucleating cells were processed without centrifugation and pipette aspiration to avoid physical stress and were directly observed by differential interference contrast (DIC) microscopy. Enucleation initiated at day 12 and the enucleation ratio (percent of enucleated reticulocytes in total cells) reached a maximum at day 14 with a value of 63 ± 7%. The direct observation by DIC microscopy showed 61 ± 9% of enucleation ratio at day 14. The human erythroblasts enucleated without contact with macrophage. The time required for enucleation was 8.4 ± 3.4 min. The enucleation rate was 1.16 ± 0.42%/h at day 12 and then decreased with a time dependent manner. The expelled nucleus was connected to the reticulocyte through plasma membrane and associated cytoskeletal elements, and spontaneous separation of the extruded nucleus from reticulocyte was extremely rare. In conclusion, human erythroblasts enucleate in a relatively short period without contact with macrophages, but nascent reticulocytes fail to completely separate from nuclei in the absence of macrophages, unless some physical force is applied to them.
Appendix
Available only for authorised users
Literature
1.
go back to reference Bessis M, Mize C, Prenant M. Erythropoiesis: comparison of in vivo and in vitro amplification. Blood Cells. 1978;4:155–74.PubMed Bessis M, Mize C, Prenant M. Erythropoiesis: comparison of in vivo and in vitro amplification. Blood Cells. 1978;4:155–74.PubMed
3.
go back to reference Hanspal M. Importance of cell–cell interactions in regulation of erythropoiesis. Curr Opin Hematol. 1997;4:142–7.CrossRefPubMed Hanspal M. Importance of cell–cell interactions in regulation of erythropoiesis. Curr Opin Hematol. 1997;4:142–7.CrossRefPubMed
8.
go back to reference Mankelow TJ, Spring FA, Parsons SF, et al. Identification of critical amino-acid residues on the erythroid intercellular adhesion molecule-4 (ICAM-4) mediating adhesion to V integrins. Blood. 2004;103:1503–8. doi:10.1182/blood-2003-08-2792.CrossRefPubMed Mankelow TJ, Spring FA, Parsons SF, et al. Identification of critical amino-acid residues on the erythroid intercellular adhesion molecule-4 (ICAM-4) mediating adhesion to V integrins. Blood. 2004;103:1503–8. doi:10.​1182/​blood-2003-08-2792.CrossRefPubMed
9.
go back to reference Yoshida H, Kawane K, Koike M, Mori Y, Uchiyama Y, Nagata S. Phosphatidylserine-dependent engulfment by macrophages of nuclei from erythroid precursor cells. Nature. 2005;437:754–8. doi:10.1038/nature03964.CrossRefPubMed Yoshida H, Kawane K, Koike M, Mori Y, Uchiyama Y, Nagata S. Phosphatidylserine-dependent engulfment by macrophages of nuclei from erythroid precursor cells. Nature. 2005;437:754–8. doi:10.​1038/​nature03964.CrossRefPubMed
11.
go back to reference Giarratana MC, Kobari L, Lapillonne H, et al. Ex vivo generation of fully mature human red blood cells from hematopoietic stem cells. Nat Biotechnol. 2005;23:69–74. doi:10.1038/nbt1047.CrossRefPubMed Giarratana MC, Kobari L, Lapillonne H, et al. Ex vivo generation of fully mature human red blood cells from hematopoietic stem cells. Nat Biotechnol. 2005;23:69–74. doi:10.​1038/​nbt1047.CrossRefPubMed
12.
13.
go back to reference Hanspal M, Hanspal JS. The association of erythroblasts with macrophages promotes erythroid proliferation and maturation: a 30-kD heparin-binding protein is involved in this contact. Blood. 1994;84:3494–504.PubMed Hanspal M, Hanspal JS. The association of erythroblasts with macrophages promotes erythroid proliferation and maturation: a 30-kD heparin-binding protein is involved in this contact. Blood. 1994;84:3494–504.PubMed
16.
go back to reference Zhang J, Socolovsky M, Gross AW, Lodish HF. Role of Ras signaling in erythroid differentiation of mouse fetal liver cells: functional analysis by a flow cytometry-based novel culture system. Blood. 2003;102:3938–46. doi:10.1182/blood-2003-05-1479.CrossRefPubMed Zhang J, Socolovsky M, Gross AW, Lodish HF. Role of Ras signaling in erythroid differentiation of mouse fetal liver cells: functional analysis by a flow cytometry-based novel culture system. Blood. 2003;102:3938–46. doi:10.​1182/​blood-2003-05-1479.CrossRefPubMed
18.
go back to reference Miharada K, Hiroyama T, Sudo K, Nagasawa T, Yukio Nakamura Y. Efficient enucleation of erythroblasts differentiated in vitro from hematopoietic stem and progenitor cells. Nat Biotechnol. 2006;24:1255–6. doi:10.1038/nbt1245.CrossRefPubMed Miharada K, Hiroyama T, Sudo K, Nagasawa T, Yukio Nakamura Y. Efficient enucleation of erythroblasts differentiated in vitro from hematopoietic stem and progenitor cells. Nat Biotechnol. 2006;24:1255–6. doi:10.​1038/​nbt1245.CrossRefPubMed
19.
go back to reference Oda A, Sawada K, Druker BJ, et al. Erythropoietin induces tyrosine phosphorylation of Jak2, STAT5A and STAT5B in primary cultured human erythroid precursors. Blood. 1998;92:443–51.PubMed Oda A, Sawada K, Druker BJ, et al. Erythropoietin induces tyrosine phosphorylation of Jak2, STAT5A and STAT5B in primary cultured human erythroid precursors. Blood. 1998;92:443–51.PubMed
20.
go back to reference Saito K, Hirokawa M, Inaba K, et al. Phagocytosis of co-developing megakaryocytic progenitors by dendritic cells in culture with thrombopoietin and tumor necrosis factor-α and its possible role in hemophagocytic syndrome. Blood. 2006;107:1366–74. doi:10.1182/blood-2005-08-3155.CrossRefPubMed Saito K, Hirokawa M, Inaba K, et al. Phagocytosis of co-developing megakaryocytic progenitors by dendritic cells in culture with thrombopoietin and tumor necrosis factor-α and its possible role in hemophagocytic syndrome. Blood. 2006;107:1366–74. doi:10.​1182/​blood-2005-08-3155.CrossRefPubMed
24.
go back to reference Muta K, Krantz SB, Bundurant MC, Dai C. Stem cell factor retards differentiation of normal human erythroid progenitor cells while stimulating proliferation. Blood. 1995;86:572–80.PubMed Muta K, Krantz SB, Bundurant MC, Dai C. Stem cell factor retards differentiation of normal human erythroid progenitor cells while stimulating proliferation. Blood. 1995;86:572–80.PubMed
25.
go back to reference Rind H. Kinetik der erythroblastenentkernung. Folia Haematol Int Mag Klin Morphol Blutforsch. 1956;74:262–6.PubMed Rind H. Kinetik der erythroblastenentkernung. Folia Haematol Int Mag Klin Morphol Blutforsch. 1956;74:262–6.PubMed
Metadata
Title
Dynamics of human erythroblast enucleation
Authors
Miwa Hebiguchi
Makoto Hirokawa
Yong-Mei Guo
Kunie Saito
Hideki Wakui
Atsushi Komatsuda
Naohito Fujishima
Naoto Takahashi
Tsutomu Takahashi
Takehiko Sasaki
Wataru Nunomura
Yuichi Takakuwa
Kenichi Sawada
Publication date
01-12-2008
Publisher
Springer Japan
Published in
International Journal of Hematology / Issue 5/2008
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI
https://doi.org/10.1007/s12185-008-0200-6

Other articles of this Issue 5/2008

International Journal of Hematology 5/2008 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine